Cargando…
Granulomatous myositis induced by anti–PD-1 monoclonal antibodies
Autores principales: | Uchio, Naohiro, Taira, Kenichiro, Ikenaga, Chiseko, Unuma, Atsushi, Kadoya, Masato, Kubota, Akatsuki, Toda, Tatsushi, Shimizu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830477/ http://dx.doi.org/10.1212/NXI.0000000000000464 |
Ejemplares similares
-
Inflammatory myopathy with myasthenia gravis: Thymoma association and polymyositis pathology
por: Uchio, Naohiro, et al.
Publicado: (2018) -
Pembrolizumab on pre-existing inclusion body myositis: a case report
por: Uchio, Naohiro, et al.
Publicado: (2020) -
Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy
por: Kadoya, Masato, et al.
Publicado: (2016) -
Muscle Transcriptomics Shows Overexpression of Cadherin 1 in Inclusion Body Myositis
por: Ikenaga, Chiseko, et al.
Publicado: (2022) -
Repeated treatments with rituximab in a patient with amyloid-like IgM deposition neuropathy
por: Kadoya, Masato, et al.
Publicado: (2016)